about
Regulatable systemic production of monoclonal antibodies by in vivo muscle electroporationTherapeutic and prevention strategies against human enterovirus 71 infectionCoexpression of GM-CSF and antigen in DNA prime-adenoviral vector boost immunization enhances polyfunctional CD8+ T cell responses, whereas expression of GM-CSF antigen fusion protein induces autoimmunityOptimization of codon usage enhances the immunogenicity of a DNA vaccine encoding mycobacterial antigen Ag85BEP3 receptor isoforms are differentially expressed in subpopulations of primate granulosa cells and couple to unique G-proteinsCodon-Optimized Expression and Purification of Truncated ORF2 Protein of Hepatitis E Virus in Escherichia coliGene therapy progress and prospects: Duchenne muscular dystrophy.The porcine circovirus type 1 capsid gene promoter improves antigen expression and immunogenicity in a HIV-1 plasmid vaccineGene therapy progress and prospects: recent progress in transgene and RNAi expression cassettes.Immunogenicity of a novel enhanced consensus DNA vaccine encoding the leptospiral protein LipL45Use of attenuated bacteria as delivery vectors for DNA vaccines.A DNA vaccine against Escherichia coli O157:H7.Enhancement of DNA tumor vaccine efficacy by gene gun-mediated codelivery of threshold amounts of plasmid-encoded helper antigen.Enhancement of the expression of HCV core gene does not enhance core-specific immune response in DNA immunization: advantages of the heterologous DNA prime, protein boost immunization regimenPosttranscriptional regulatory elements enhance antigen expression and DNA vaccine efficacy.Progress in the development of genetic immunization.Development of an ex vivo human skin model for intradermal vaccination: tissue viability and Langerhans cell behaviour.Transcriptional IL-15-directed in vivo DC targeting DNA vaccine.Vaccination approaches against Trypanosoma cruzi infection.Oxidative stress induced by HIV-1 reverse transcriptase modulates the enzyme's performance in gene immunization.In vivo electroporation of minicircle DNA as a novel method of vaccine delivery to enhance HIV-1-specific immune responses.Development of enzyme-linked immunosorbent assays using 2 truncated ORF2 proteins for detection of IgG antibodies against hepatitis E virusDNA immunization as an efficient strategy for vaccination.Induction of multiple cytotoxic T lymphocyte responses in mice by a multiepitope DNA vaccine against dengue virus serotype 1.An HDAC inhibitor enhances cancer therapeutic efficiency of RNA polymerase III promoter-driven IDO shRNA.Sindbis virus replicase-based DNA vaccine construct encoding FMDV-specific multivalent epitope gene: studies on its immune responses in guinea pigs.Complexes of streptavidin-fused antigens with biotinylated antibodies targeting receptors on dendritic cell surface: a novel tool for induction of specific T-cell immune responses.Liposomal delivery of p-ialB and p-omp25 DNA vaccines improves immunogenicity but fails to provide full protection against B. melitensis challenge.Optimized FaeG expression and a thermolabile enterotoxin DNA adjuvant enhance priming of an intestinal immune response by an FaeG DNA vaccine in pigs.Suppression of breast tumor growth by DNA vaccination against phosphatase of regenerating liver 3.Co-expression of S. Typhi GroEL and IL-22 gene augments immune responses against Salmonella infection.Differential immune response in mice immunized with the A, R or C domain from TcSP protein of Trypanosoma cruzi or with the coding DNAs.Improved expression of secretory and trimeric proteins in mammalian cells via the introduction of a new trimer motif and a mutant of the tPA signal sequence.DNA vaccines for prostate cancer.Live Bacterial Vectors-A Promising DNA Vaccine Delivery System.Biomaterials at the interface of nano- and micro-scale vector-cellular interactions in genetic vaccine design.Leishmania vaccines: from leishmanization to the era of DNA technology
P2860
Q24806498-FA40ECFB-A731-4216-A9ED-5D65C5204D74Q28080796-3BC4A848-4FFA-4E92-8D10-9C0FB70A3FDCQ33327757-ED165CBF-534E-4576-9116-1A350129E715Q34033825-C6180E15-B4D2-4B28-80EF-C3C0CF00F1EDQ34373002-E756B5A7-9B7D-4FC1-8D50-5C589E4EE248Q34437470-BE0542C7-3AB8-45EC-B609-12EE6E031281Q34576814-A60D61FD-8AC5-45E4-A380-4FE98FD86BECQ34586248-1FBFEEE2-82C1-4D65-9155-F1BF960AEE0CQ36091296-3EDD6BD0-242D-4D16-ACB0-CE3B6DF2BD99Q36256428-1E618386-DE01-4340-9D8C-07AB509B5135Q36728805-1FB2E8E9-5063-4592-9A40-1CCB55577A39Q36777146-EEC091D9-7764-4B6F-B4A6-EFA04864ED5DQ37039140-F0F8B3C2-9C6B-431E-B7F6-794ABED35334Q37242521-689451BF-4A81-4983-97DE-71C3D10463A5Q37284470-837769F4-D599-4FAC-8312-F48F60B77FFBQ37316018-947C4A4D-BC0C-4B1E-9A8E-B0211733C85BQ37366646-BCAA04E4-4F94-4DEC-AC7C-3F25016C6FFFQ37388709-DB926657-2901-4A2E-9FDA-F0A3A176A4B5Q37524046-15E9F3B1-DFC5-456D-AC4F-EDD813116A42Q37530475-66C58FC8-4257-4040-84F8-6537A3BE6B32Q37547141-9228D70E-50E4-4CDF-8C72-FC23A3D8F01BQ37628823-D587F690-C2CA-4D25-9215-20B5B83CA7DCQ38081358-256EAE2C-869F-4F01-8ECC-963CEAD8C06AQ38942473-0FA6178A-2873-4771-824E-572D5CB55E1FQ39150897-13A7F689-3A97-47D9-A038-1EF705941CC3Q39330599-D92D3B3E-C344-4A5F-91D1-9821C58CB898Q39456671-22CEDA16-0CEB-45BE-9DAA-1AC4EE6BFBAAQ41761576-24EE8A79-5513-4A01-8DC4-FAA7D56B5154Q41879113-44C648E1-B226-4107-9392-14E5221C6331Q43522873-EAD265D9-425E-44D2-BBC4-36C94673B757Q43855252-F8A54252-B650-4FC9-99C2-E61608FB7375Q44270532-3A5675C3-26F7-457B-AC11-B4E874E9A009Q51009640-27E7D159-20FA-4716-B90C-94197E5C4C20Q51142505-BFCEFD5B-3616-4304-9F23-B965032B3454Q52640510-D107902B-52D2-4758-9BB6-1A0B0C633D0AQ55432126-15A1C922-3923-436C-92CC-29A8027C47D9Q56157155-F931BFE9-7FFD-4475-BB35-C4DBC30CD369
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
DNA vaccines: improving expression of antigens
@ast
DNA vaccines: improving expression of antigens
@en
DNA vaccines: improving expression of antigens
@nl
type
label
DNA vaccines: improving expression of antigens
@ast
DNA vaccines: improving expression of antigens
@en
DNA vaccines: improving expression of antigens
@nl
prefLabel
DNA vaccines: improving expression of antigens
@ast
DNA vaccines: improving expression of antigens
@en
DNA vaccines: improving expression of antigens
@nl
P2860
P356
P1476
DNA vaccines: improving expression of antigens
@en
P2093
Helen S Garmory
Katherine A Brown
P2860
P2888
P356
10.1186/1479-0556-1-2
P577
2003-09-16T00:00:00Z
P5875
P6179
1031120576